Compare up to 4 stocks side by side, across all 7 of StockIQ's scoring categories.
| Category | TNGX Tango Therapeutics, Inc. | AAPG Ascentage Pharma Group International - American Depository |
|---|---|---|
| Price | $24.92 +1.2% | $14.86 -2.5% |
| StockIQ Score | 52C- Moderate Risk: High | 36F Weak Risk: Medium |
| Technical | 64C+ | 13F |
| Fundamental | 30F | 35F |
| Growth | 68B- | 50C- |
| Fair Value | 38F | 38F |
| News | 62C+ | 50C- |
| Quality | 58C | 50C- |
| Risk | 40D | 48D+ |
Scores are based on real financial data only and do not constitute investment advice. How the score is calculated
Tango Therapeutics (TNGX) outperforms Ascentage Pharma (AAPG) in growth, scoring 68 versus 50. Both share identical investor scores of 37 and valuation scores of 38, but TNGX’s technical score (9) is far weaker than AAPG’s (18). AAPG leads in fundamentals with a 35 versus TNGX’s 30.
